Evidence map›Paper›PMID 23539366›Full record

ArticleWorld journal of gastroenterology2013

Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.

Ekaterini Chatzaki, Peter A Anton, Mulugeta Million, Maria Lambropoulou, Theodoros Constantinidis, George Kolios, Yvette Taché, Dimitri E Grigoriadis

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases.World journal of gastrointestinal pathophysiology · 2021
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.Journal of neurogastroenterology and motility · 2015
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ekaterini ChatzakiNeurocrine Biosciences Inc., San Diego, CA 92121, USA. achatzak@med.duth.gr
Peter A Anton
Mulugeta Million
Maria Lambropoulou
Theodoros Constantinidis
George Kolios
Yvette Taché
Dimitri E Grigoriadis
Neurocrine Biosciences (United States) · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Stress-Induced Activition of Colonic Motor FunctionR01DK057238 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TACHE, YVETTE FRANCE · 2000 to 2015
$3.3M
Modulation of Colonic Response to Stress by Peripheral CRF2 ReceptorsR01DK078676 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MULUGETA, MILLION · 2008 to 2016
$2.2M
NIDDK NIH HHS DK-41301NIDDK NIH HHS DK-78676NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK057238NIDDK NIH HHS R01 DK078676NIDDK NIH HHS R01 DK-57238
6 · The paper itself

Abstract

aimTo assess corticotropin-releasing factor receptor 2 (CRF2) expression in the colon of healthy subjects and patients with ulcerative colitis (UC).

methodsWe examined CRF2 gene and protein expression in the distal/sigmoid colonic mucosal biopsies from healthy subjects and patients with UC (active or disease in remission), human immunodeficiency virus (HIV) and functional bowel disease (FBD) by reverse transcription-polymerase chain reaction and immunofluorescence.

resultsGene expression of CRF2 was demonstrated in the normal human colonic biopsies, but not in the human colorectal adenocarcinoma cell line Caco2. Receptor protein localization showed immunoreactive CRF2 receptors in the lamina propria and in the epithelial cells of the distal/sigmoid biopsy samples. Interestingly, CRF2 immunoreactivity was no longer observed in epithelial cells of patients with mild-moderately active UC and disease in remission, while receptor protein expression did not change in the lamina propria. No differences in CRF2 expression profile were observed in distal/sigmoid intestinal biopsies from HIV infection and FBD patients, showing no signs of inflammation.

conclusionThe down-regulation of the CRF2 receptor in the distal/sigmoid biopsies of UC patients is indicative of change in CRF2 signalling associated with the process of inflammation.

Indexed as

AdultAgedAged, 80 and overAnti-Inflammatory AgentsBiopsyCaco-2 CellsCase-Control StudiesColitis, UlcerativeColonDown-RegulationFemaleGastrointestinal AgentsGenetic MarkersHumansIntestinal MucosaMaleAnti-Inflammatory AgentsCRF receptor type 2Gastrointestinal AgentsGenetic MarkersReceptors, Corticotropin-Releasing HormoneColonic mucosaCorticotropin-releasing factorCorticotropin-releasing factor receptorHuman immunodeficiency virusUlcerative colitisUrocortin

Identifiers

PMID23539366
PMCPMC3602501
OpenAlexW2113159304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.